TXG

10X Genomics (TXG) Market Capitalization Overview
Market Cap: $9.14B as of Oct 30, 2026
$9.14B
$2.60B (22.13%)past month
As of Oct 30, 2026, 10X Genomics (TXG) has a market capitalization of $9.14B. Over the past 30 days, its market cap has increased by 47.98%, while in the last 12 months, it has increased by 342.56%.
Market capitalization represents the total value of 10X Genomics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
10X Genomics (TXG) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of 10X Genomics (TXG) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of 10X Genomics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
10X Genomics (TXG) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of 10X Genomics (TXG) helps investors assess the company's size and compare it with competitors for better investment decisions.
10X Genomics (TXG) Market Cap & Key Trends
See 10X Genomics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in 10X Genomics (TXG)
Order type
Buy in
Order amount
Est. shares
0 shares
10X Genomics (TXG) Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Oct 1, 2026 | $11.57B | +47.98% |
| Sep 1, 2026 | $7.82B | +30.94% |
| Aug 3, 2026 | $5.97B | +20.38% |
| Jul 1, 2026 | $4.96B | +31.97% |
| Jun 1, 2026 | $3.76B | +29.84% |
| May 1, 2026 | $2.90B | +2.71% |
| Apr 1, 2026 | $2.82B | -4.71% |
| Mar 2, 2026 | $2.96B | +17.09% |
| Feb 2, 2026 | $2.53B | +20.04% |
| Jan 2, 2026 | $2.11B | -8.08% |
10X Genomics (TXG) End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $9.14B | +342.56% |
| 2025 | $2.07B | +18.74% |
| 2024 | $1.74B | -73.72% |
| 2023 | $6.62B | +58.59% |
| 2022 | $4.18B | -74.93% |
| 2021 | $16.64B | — |
FAQs About 10X Genomics (TXG) Market Cap
As of Oct 30, 2026, the market capitalization of 10X Genomics (TXG) is $9.14B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, 10X Genomics’s market capitalization has decreased by -22.13%, changing from $11.74B to $9.14B as of Oct 30, 2026.
In the last 3 months, 10X Genomics’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, 10X Genomics’s market capitalization increased from $1.74B in January to $2.07B in December, reflecting a 18.74% change.
In the past five years, 10X Genomics (TXG) has had a compound annual growth rate (CAGR) of -34.13% in market capitalization. This means its market cap has shrunk at an average rate of -34.13% per year.
10X Genomics (TXG) Market Cap & Key Trends
See 10X Genomics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in 10X Genomics (TXG)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.